Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. [electronic resource]
Producer: 20120504Description: 1352-9 p. digitalISSN:- 1557-3117
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- genetics
- Aging -- immunology
- Child
- Cytochrome P-450 CYP3A -- genetics
- Dose-Response Relationship, Drug
- Female
- Genotype
- Glomerular Filtration Rate -- physiology
- Graft Rejection -- immunology
- Heart Transplantation -- immunology
- Humans
- Immunosuppressive Agents -- pharmacokinetics
- Kidney -- physiology
- Male
- Retrospective Studies
- Severity of Illness Index
- Tacrolimus -- pharmacokinetics
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.